Literature DB >> 29042980

Diagnosis and treatment of pulmonary mucormycosis: A case report.

Zhiming Luo1, Lin Zhang1.   

Abstract

Pulmonary mucormycosis, a relatively rare pulmonary fungal disease, is difficult to diagnose and lacks effective treatment. The present study reports the case of a 64-year-old patient who was treated successfully for pulmonary mucormycosis in Xuan Wu Hospital. The patient presented with low-grade fever and a productive cough that persisted for 1 month with no evident cause, and also suffered from diabetes mellitus. Prior antibiotic treatment with levofloxacin had been ineffective. Culture of mucus obtained by bronchoscopy resulted in a diagnosis of pulmonary mucormycosis. The patient received a cumulative dose of 1,355 mg amphotericin B over 2 months and presented a full recovery.

Entities:  

Keywords:  diagnosis; pulmonary mucormycosis; treatment

Year:  2017        PMID: 29042980      PMCID: PMC5639346          DOI: 10.3892/etm.2017.4986

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  14 in total

Review 1.  Rhino-orbitocerebral mucormycosis attributable to Apophysomyces elegans in an immunocompetent individual: case report and review of the literature.

Authors:  L Garcia-Covarrubias; R Bartlett; D M Barratt; R J Wassermann
Journal:  J Trauma       Date:  2001-02

Review 2.  A diagnosis neglected for 6 years: report of a misdiagnosed case of pulmonary mucormycosis and review of the literature.

Authors:  Wen-fang Li; Chao He; Xue-feng Liu; Sheng-yun Wang; Jin-long Qu; Zhao-fen Lin
Journal:  Chin Med J (Engl)       Date:  2010-09       Impact factor: 2.628

3.  [A multicentre retrospective study of pulmonary mycosis clinically proven from 1998 to 2007].

Authors:  You-Ning Liu; Dan-Yang She; Tie-Ying Sun; Zhao-Hui Tong; Bei He; Yi Xiao; Li-Xian He; Jie-Ming Qu; Xiao-Qing Liu; Er-Ran Li; Ping Chen; Zhong-Sen Ma; Yi Shi; Yu-Lin Feng; Shu-Juan Jiang; Sheng-Dao Xiong; Cheng-Ping Hu
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  2011-02

Review 4.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Authors:  Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

5.  Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007.

Authors:  A Skiada; L Pagano; A Groll; S Zimmerli; B Dupont; K Lagrou; C Lass-Florl; E Bouza; N Klimko; P Gaustad; M Richardson; P Hamal; M Akova; J F Meis; J-L Rodriguez-Tudela; E Roilides; A Mitrousia-Ziouva; G Petrikkos
Journal:  Clin Microbiol Infect       Date:  2011-07-01       Impact factor: 8.067

6.  [Pulmonary mucormycosis: report of 5 cases and review of 46 cases reported in China].

Authors:  Yi-meng Yang; Bao-min Fang; Xiao-mao Xu; Fang Fang; Ming-ming Pan; Xue-feng Zhong; Tie-ying Sun
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  2013-08

7.  In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes.

Authors:  Qiu N Sun; Annette W Fothergill; Dora I McCarthy; Michael G Rinaldi; John R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

Review 8.  Pulmonary mucormycosis: results of medical and surgical therapy.

Authors:  M Tedder; J A Spratt; M P Anstadt; S S Hegde; S D Tedder; J E Lowe
Journal:  Ann Thorac Surg       Date:  1994-04       Impact factor: 4.330

Review 9.  Recent advances in the management of mucormycosis: from bench to bedside.

Authors:  Brad Spellberg; Thomas J Walsh; Dimitrios P Kontoyiannis; John Edwards; Ashraf S Ibrahim
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

10.  Tracheal mucormycosis presented as an intraluminal soft tissue mass.

Authors:  Omer Wolf; Ziv Gil; Leonor Leider-Trejo; Avi Khafif; Philippe Biderman; Dan M Fliss
Journal:  Head Neck       Date:  2004-06       Impact factor: 3.147

View more
  3 in total

1.  Pulmonary mucormycosis mimicking lung tumour in an uncontrolled diabetic patient.

Authors:  Elham Sadat Banimostafavi; Mahdi Fakhar; Zakaria Zakariaei; Ali Sharifpour; Mostafa Soleymani
Journal:  Respirol Case Rep       Date:  2022-02-23

Review 2.  Storm of a rare opportunistic life threatening mucormycosis among post COVID-19 patients: A tale of two pathogens.

Authors:  Mohan Bilikallahalli Sannathimmappa; Vinod Nambiar; Rajeev Aravindakshan
Journal:  Int J Crit Illn Inj Sci       Date:  2022-03-24

3.  Pulmonary Mucormycosis: A Case Report of a Rare Infection with Potential Diagnostic Problems.

Authors:  Salwa O Mekki; Amal A Hassan; Afnan Falemban; Nashwa Alkotani; Salem M Alsharif; Ahmed Haron; Basim Felemban; Mohammad S Iqbal; Aisha Tabassum
Journal:  Case Rep Pathol       Date:  2020-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.